257 related articles for article (PubMed ID: 16817122)
1. [Familial breast cancer: what the radiologist needs to know].
Kuhl CK
Rofo; 2006 Jul; 178(7):680-7. PubMed ID: 16817122
[TBL] [Abstract][Full Text] [Related]
2. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
Kuhl CK
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
Chappuis PO
Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
[TBL] [Abstract][Full Text] [Related]
5. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
[TBL] [Abstract][Full Text] [Related]
6. MR imaging for surveillance of women at high familial risk for breast cancer.
Kuhl CK
Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer susceptibility testing: past, present and future.
Goldberg JI; Borgen PI
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1205-14. PubMed ID: 16925486
[TBL] [Abstract][Full Text] [Related]
8. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
9. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
Hoskins KF; Zwaagstra A; Ranz M
Cancer; 2006 Oct; 107(8):1769-76. PubMed ID: 16967460
[TBL] [Abstract][Full Text] [Related]
10. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.
Warner E; Heisey RE; Goel V; Carroll JC; McCready DR
Can Fam Physician; 1999 Jan; 45():104-12. PubMed ID: 10889863
[TBL] [Abstract][Full Text] [Related]
12. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
13. Strategies for ovarian cancer prevention.
Dann RB; Kelley JL; Zorn KK
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
[TBL] [Abstract][Full Text] [Related]
14. Role of MRI in screening women at high risk for breast cancer.
Lehman CD
J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
[TBL] [Abstract][Full Text] [Related]
15. [Revised practice guideline 'Screening and diagnosis of breast cancer'].
Zonderland HM; Tuut MK; den Heeten GJ; Asperen CJ; de Bock GH; Rutqers EJ; Westenend PJ; Smit GM; Benraadt J
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2336-9. PubMed ID: 19024064
[TBL] [Abstract][Full Text] [Related]
16. Screening for hereditary breast cancer.
Dent R; Warner E
Semin Oncol; 2007 Oct; 34(5):392-400. PubMed ID: 17920893
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening for Korean women must consider traditional risks as well as two genetic risk factors: genetic polymorphisms and inheritable gene mutations.
Anderson G; Jun M; Choi K
Cancer Nurs; 2007; 30(3):213-22. PubMed ID: 17510585
[TBL] [Abstract][Full Text] [Related]
18. The prevention of hereditary breast cancer.
Rodriquez E; Domchek SM
Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
Dawson SJ; Price MA; Jenkins MA; McKinley JM; Butow PN; McLachlan SA; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA
J Clin Oncol; 2008 Jan; 26(2):225-32. PubMed ID: 18040054
[TBL] [Abstract][Full Text] [Related]
20. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
